A multidisciplinary approach to the diagnosis and management of Wilson disease: Executive summary of the 2022 Practice Guidance on Wilson disease from the American Association for the Study of Liver Diseases
- PMID: 36152019
- DOI: 10.1002/hep.32805
A multidisciplinary approach to the diagnosis and management of Wilson disease: Executive summary of the 2022 Practice Guidance on Wilson disease from the American Association for the Study of Liver Diseases
References
-
- Sandahl TD, Laursen TL, Munk DE, Vilstrup H, Weiss KH, Ott P. The prevalence of Wilson's disease: an update. Hepatology. 2020;71:722–32.
-
- Wallace DF, Dooley JS. ATP7B variant penetrance explains differences between genetic and clinical prevalence estimates for Wilson disease. Hum Genet. 2020;139:1065–75.
-
- Wilson DC, Phillips MJ, Cox DW, Roberts EA. Severe hepatic Wilson's disease in preschool‐aged children. J Pediatr. 2000;137:719–22.
-
- Wiernicka A, Dądalski M, Jańczyk W, Kamińska D, Naorniakowska M, Hüsing‐Kabar A, et al. Early onset of Wilson disease: diagnostic challenges. J Pediatr Gastroenterol Nutr. 2017;65:555–60.
-
- Ala A, Borjigin J, Rochwarger A, Schilsky M. Wilson disease in septuagenarian siblings: raising the bar for diagnosis. Hepatology. 2005;41:668–70.

